Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reichardt

Showing results (21-30 of 193) with videos related to

Pageof 20
Sort By:
European Journal of Immunology|December 3, 2009
Imaging immunityPeter Reichardt, Günter Hämmerling, Matthias Gunzer
Current Topics in Microbiology and Immunology|December 5, 2009
APC, T cells, and the immune synapsePeter Reichardt, Bastian Dornbach, Matthias Gunzer
Methods in Molecular Biology (Clifton, N.J.)|September 19, 2007
Analyzing the physicodynamics of immune cells in a three-dimensional collagen matrixPeter Reichardt, Frank Gunzer, Matthias Gunzer
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 28, 2025
Siyer Roohani, Reinhardt Krcek, Peter Reichardt
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|September 3, 2004
Development of and clinical experience with capecitabine (Xeloda) in the treatment of solid tumoursCora N Sternberg, Peter Reichardt, Michelle Holland
Cancer Chemotherapy and Pharmacology|August 13, 2013
New fronts in the adjuvant treatment of GISTPeter Reichardt, Heikki Joensuu, Jean-Yves Blay
Cancer|September 16, 2003
Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinomaPierre Fumoleau, Joanne L Blum, Peter Reichardt
Cancer Treatment Reviews|June 24, 2010
Practical management of tyrosine kinase inhibitor-associated side effects in GISTHeikki Joensuu, Jonathan C Trent, Peter Reichardt
Expert Review of Anticancer Therapy|February 6, 2010
Towards global consensus in the treatment of gastrointestinal stromal tumorPeter Reichardt, Jean-Yves Blay, Margaret von Mehren
Future Oncology (London, England)|December 6, 2016
The importance of treating by histological subtype in advanced soft tissue sarcomaJavier Martín Broto, Axel Le Cesne, Peter Reichardt
Pageof 20

Showing results (21-30 of 193) with videos related to

Sort By:
Pageof 20
European Journal of Immunology|December 3, 2009
Imaging immunityPeter Reichardt, Günter Hämmerling, Matthias Gunzer
Current Topics in Microbiology and Immunology|December 5, 2009
APC, T cells, and the immune synapsePeter Reichardt, Bastian Dornbach, Matthias Gunzer
Methods in Molecular Biology (Clifton, N.J.)|September 19, 2007
Analyzing the physicodynamics of immune cells in a three-dimensional collagen matrixPeter Reichardt, Frank Gunzer, Matthias Gunzer
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 28, 2025
Siyer Roohani, Reinhardt Krcek, Peter Reichardt
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|September 3, 2004
Development of and clinical experience with capecitabine (Xeloda) in the treatment of solid tumoursCora N Sternberg, Peter Reichardt, Michelle Holland
Cancer Chemotherapy and Pharmacology|August 13, 2013
New fronts in the adjuvant treatment of GISTPeter Reichardt, Heikki Joensuu, Jean-Yves Blay
Cancer|September 16, 2003
Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinomaPierre Fumoleau, Joanne L Blum, Peter Reichardt
Cancer Treatment Reviews|June 24, 2010
Practical management of tyrosine kinase inhibitor-associated side effects in GISTHeikki Joensuu, Jonathan C Trent, Peter Reichardt
Expert Review of Anticancer Therapy|February 6, 2010
Towards global consensus in the treatment of gastrointestinal stromal tumorPeter Reichardt, Jean-Yves Blay, Margaret von Mehren
Future Oncology (London, England)|December 6, 2016
The importance of treating by histological subtype in advanced soft tissue sarcomaJavier Martín Broto, Axel Le Cesne, Peter Reichardt
Pageof 20